Browsing College of Pharmacy by Subject "Obese"
Now showing items 1-2 of 2
-
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
( Springer Nature , 2022 , Article)Venous thromboembolism (VTE) is a leading cause of morbidity and mortality globally. The direct oral anticoagulants, including rivaroxaban, are relatively novel therapeutic options in the treatment and prevention of VTE. ... -
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
( Springer Science and Business Media Deutschland GmbH , 2023 , Article)Purpose To investigate real-world prescribing trends and clinical outcomes based on body mass index (BMI) categorization in patients who received rivaroxaban therapy. Methods This was a retrospective cohort study ...